Literature DB >> 19173072

Structural and biological investigation of ferrocene-substituted 3-methylidene-1,3-dihydro-2H-indol-2-ones.

John Spencer1, Andrew P Mendham, Arun K Kotha, Simon C W Richardson, Elizabeth A Hillard, Gérard Jaouen, Louise Male, Michael B Hursthouse.   

Abstract

The Knoevenagel condensation of 1,3-dihydro-2H-indol-2-one with ferrocene carboxaldehyde afforded an approximate 2:1 mixture of the geometrical isomers (E)- and (Z)-3-ferrocenylmethylidene-1,3-dihydro-2H-indol-2-one respectively in an overall 67% yield; the air and solution-stable isomers were readily separated by preparative thin layer chromatography and their structures were unequivocally elucidated in solution, by (1)H NMR spectroscopy, and in the solid phase, by X-ray crystallography; both isomers of displayed in vitro toxicity against B16 melanoma and Vero cell lines in the micromolar range and inhibited the kinase VEGFR-2 with IC(50) values of ca. 200 nM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19173072     DOI: 10.1039/b816249b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  12 in total

1.  Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

Authors:  Sebastian Blanck; Thomas Cruchter; Adina Vultur; Radostan Riedel; Klaus Harms; Meenhard Herlyn; Eric Meggers
Journal:  Organometallics       Date:  2011-07-18       Impact factor: 3.876

2.  The art of filling protein pockets efficiently with octahedral metal complexes.

Authors:  Sebastian Blanck; Jasna Maksimoska; Julia Baumeister; Klaus Harms; Ronen Marmorstein; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-01       Impact factor: 15.336

3.  Novel palladium(II) complexes containing a sulfur ligand: structure and biological activity on HeLa cells.

Authors:  EnJun Gao; Feng Guan; XiaNan Gao; MingChang Zhu; Lei Liu; ChuanSheng Wang; WanZhong Zhang; YaGuang Sun
Journal:  J Biol Inorg Chem       Date:  2011-10-11       Impact factor: 3.358

4.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

Review 5.  A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets.

Authors:  Joost C M Uitdehaag; Folkert Verkaar; Husam Alwan; Jos de Man; Rogier C Buijsman; Guido J R Zaman
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

7.  Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors.

Authors:  John Spencer; Jahangir Amin; Minghua Wang; Graham Packham; Sharifah S Syed Alwi; Graham J Tizzard; Simon J Coles; Ronald M Paranal; James E Bradner; Tom D Heightman
Journal:  ACS Med Chem Lett       Date:  2011-03-18       Impact factor: 4.345

Review 8.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

9.  Synthesis and solid-state characterisation of 4-substituted methylidene oxindoles.

Authors:  Graham J Tizzard; Simon J Coles; Mark Edwards; Romanus Oforbike Onyeabo; Mark Allen; John Spencer
Journal:  Chem Cent J       Date:  2013-12-20       Impact factor: 4.215

10.  Non-ATP-Mimetic Organometallic Protein Kinase Inhibitor.

Authors:  Kathrin Wähler; Katja Kräling; Holger Steuber; Eric Meggers
Journal:  ChemistryOpen       Date:  2013-09-05       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.